Skip to main content
Cidara Therapeutics, Inc. logo

Cidara Therapeutics, Inc. — Investor Relations & Filings

Ticker · CDTX ISIN · US1717572069 LEI · 549300IHQ9Z7RI1X2D22 US Manufacturing
Open in API
Filings indexed 793 across all filing types
Latest filing 2018-04-26 Board/Management Inform…
Country US United States of America
Listing US CDTX

About Cidara Therapeutics, Inc.

https://www.cidara.com/

Cidara Therapeutics, Inc. is a biotechnology company that develops targeted immunotherapies and novel anti-infectives for patients with serious diseases. The company utilizes its proprietary Cloudbreak® platform to create drug-Fc conjugates (DFCs). These DFCs are engineered as 'single molecule cocktails' by coupling targeted small molecules or peptides to a human antibody fragment (Fc). This approach is designed to directly inhibit disease targets, such as fungal or viral pathogens, while simultaneously engaging the patient's immune system. The company's focus is on developing therapies for the treatment and prevention of life-threatening infections and other serious conditions.

Recent filings

Filing Released Lang Actions
FORM 8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K current report filed with the SEC, dated April 26, 2018, reporting a specific event: the departure of a director (Robert Perez) from the company's Board of Directors and the appointment of a new director (Chrysa Mineo). The content focuses on changes in the board composition and does not contain financial statements or other report types. The key section is Item 5.02, which relates to departure and election of directors. This matches the definition of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management. The document length is 2885 characters, which is consistent with a typical 8-K filing for such an event. Therefore, the correct classification is MANG with high confidence.
2018-04-26 English
FORM 4 SUBMISSION
Director's Dealing
2018-04-03 English
FORM 4 SUBMISSION
Director's Dealing
2018-04-02 English
FORM 4 SUBMISSION
Director's Dealing
2018-04-02 English
FORM 4 SUBMISSION
Director's Dealing
2018-04-02 English
FORM 4 SUBMISSION
Director's Dealing
2018-04-02 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.